A treatment that could offer new hope of survival to patients with advanced kidney cancer is available from today. When used with existing drugs, bevacizumab, sold as Avastin, doubled the average time before renal cancer carcinoma (RCC) returned in patients to 10 months.
Drug hope for kidney cancer sufferers - The Telegraph 22nd January 2008
Tuesday, January 22, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment